These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 18585670)

  • 1. The influence of food on the pharmacokinetics of piperaquine in healthy Vietnamese volunteers.
    Hai TN; Hietala SF; Van Huong N; Ashton M
    Acta Trop; 2008 Aug; 107(2):145-9. PubMed ID: 18585670
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of food on the pharmacokinetics of piperaquine and dihydroartemisinin.
    Reuter SE; Evans AM; Shakib S; Lungershausen Y; Francis B; Valentini G; Bacchieri A; Ubben D; Pace S
    Clin Drug Investig; 2015 Sep; 35(9):559-67. PubMed ID: 26293519
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacokinetics of piperaquine after repeated oral administration of the antimalarial combination CV8 in 12 healthy male subjects.
    Röshammar D; Hai TN; Friberg Hietala S; Van Huong N; Ashton M
    Eur J Clin Pharmacol; 2006 May; 62(5):335-41. PubMed ID: 16570188
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacokinetics of dihydroartemisinin and piperaquine in pregnant and nonpregnant women with uncomplicated falciparum malaria.
    Rijken MJ; McGready R; Phyo AP; Lindegardh N; Tarning J; Laochan N; Than HH; Mu O; Win AK; Singhasivanon P; White N; Nosten F
    Antimicrob Agents Chemother; 2011 Dec; 55(12):5500-6. PubMed ID: 21947392
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Open-label crossover study of primaquine and dihydroartemisinin-piperaquine pharmacokinetics in healthy adult thai subjects.
    Hanboonkunupakarn B; Ashley EA; Jittamala P; Tarning J; Pukrittayakamee S; Hanpithakpong W; Chotsiri P; Wattanakul T; Panapipat S; Lee SJ; Day NP; White NJ
    Antimicrob Agents Chemother; 2014 Dec; 58(12):7340-6. PubMed ID: 25267661
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Population pharmacokinetics of piperaquine after two different treatment regimens with dihydroartemisinin-piperaquine in patients with Plasmodium falciparum malaria in Thailand.
    Tarning J; Ashley EA; Lindegardh N; Stepniewska K; Phaiphun L; Day NP; McGready R; Ashton M; Nosten F; White NJ
    Antimicrob Agents Chemother; 2008 Mar; 52(3):1052-61. PubMed ID: 18180343
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacokinetic Interactions between Tafenoquine and Dihydroartemisinin-Piperaquine or Artemether-Lumefantrine in Healthy Adult Subjects.
    Green JA; Mohamed K; Goyal N; Bouhired S; Hussaini A; Jones SW; Koh GC; Kostov I; Taylor M; Wolstenholm A; Duparc S
    Antimicrob Agents Chemother; 2016 Dec; 60(12):7321-7332. PubMed ID: 27697758
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A population pharmacokinetic model of piperaquine in pregnant and non-pregnant women with uncomplicated Plasmodium falciparum malaria in Sudan.
    Hoglund RM; Adam I; Hanpithakpong W; Ashton M; Lindegardh N; Day NP; White NJ; Nosten F; Tarning J
    Malar J; 2012 Nov; 11():398. PubMed ID: 23190801
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacokinetics and ex vivo pharmacodynamic antimalarial activity of dihydroartemisinin-piperaquine in patients with uncomplicated falciparum malaria in Vietnam.
    Nguyen DV; Nguyen QP; Nguyen ND; Le TT; Nguyen TD; Dinh DN; Nguyen TX; Bui D; Chavchich M; Edstein MD
    Antimicrob Agents Chemother; 2009 Aug; 53(8):3534-7. PubMed ID: 19528277
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Population pharmacokinetics of dihydroartemisinin and piperaquine in pregnant and nonpregnant women with uncomplicated malaria.
    Tarning J; Rijken MJ; McGready R; Phyo AP; Hanpithakpong W; Day NP; White NJ; Nosten F; Lindegardh N
    Antimicrob Agents Chemother; 2012 Apr; 56(4):1997-2007. PubMed ID: 22252822
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Orally formulated artemisinin in healthy fasting Vietnamese male subjects: a randomized, four-sequence, open-label, pharmacokinetic crossover study.
    Hien TT; Hanpithakpong W; Truong NT; Dung NT; Toi PV; Farrar J; Lindegardh N; Tarning J; Ashton M
    Clin Ther; 2011 May; 33(5):644-54. PubMed ID: 21665048
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacokinetics of the antimalarial drug piperaquine in healthy Vietnamese subjects.
    Nguyen TC; Nguyen NQ; Nguyen XT; Bui D; Travers T; Edstein MD
    Am J Trop Med Hyg; 2008 Oct; 79(4):620-3. PubMed ID: 18840754
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Population pharmacokinetics and electrocardiographic effects of dihydroartemisinin-piperaquine in healthy volunteers.
    Chotsiri P; Wattanakul T; Hoglund RM; Hanboonkunupakarn B; Pukrittayakamee S; Blessborn D; Jittamala P; White NJ; Day NPJ; Tarning J
    Br J Clin Pharmacol; 2017 Dec; 83(12):2752-2766. PubMed ID: 28695570
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of a high-fat meal on the relative oral bioavailability of piperaquine.
    Sim IK; Davis TM; Ilett KF
    Antimicrob Agents Chemother; 2005 Jun; 49(6):2407-11. PubMed ID: 15917540
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacokinetics of piperaquine after single and multiple oral administrations in healthy volunteers.
    Liu C; Zhang R; Hong X; Huang T; Mi S; Wang N
    Yakugaku Zasshi; 2007 Oct; 127(10):1709-14. PubMed ID: 17917428
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Combining antimalarial drugs and vaccine for malaria elimination campaigns: a randomized safety and immunogenicity trial of RTS,S/AS01 administered with dihydroartemisinin, piperaquine, and primaquine in healthy Thai adult volunteers.
    von Seidlein L; Hanboonkunupakarn B; Jittamala P; Pongsuwan P; Chotivanich K; Tarning J; Hoglund RM; Winterberg M; Mukaka M; Peerawaranun P; Sirithiranont P; Doran Z; Ockenhouse CF; Ivinson K; Lee C; Birkett AJ; Kaslow DC; Singhasivanon P; Day NPJ; Dondorp AM; White NJ; Pukrittayakamee S
    Hum Vaccin Immunother; 2020; 16(1):33-41. PubMed ID: 31306084
    [No Abstract]   [Full Text] [Related]  

  • 17. Population pharmacokinetics, tolerability, and safety of dihydroartemisinin-piperaquine and sulfadoxine-pyrimethamine-piperaquine in pregnant and nonpregnant Papua New Guinean women.
    Benjamin JM; Moore BR; Salman S; Page-Sharp M; Tawat S; Yadi G; Lorry L; Siba PM; Batty KT; Robinson LJ; Mueller I; Davis TM
    Antimicrob Agents Chemother; 2015 Jul; 59(7):4260-71. PubMed ID: 25963981
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacokinetics and bioequivalence evaluation of two fixed-dose tablet formulations of dihydroartemisinin and piperaquine in Vietnamese subjects.
    Chinh NT; Quang NN; Thanh NX; Dai B; Geue JP; Addison RS; Travers T; Edstein MD
    Antimicrob Agents Chemother; 2009 Feb; 53(2):828-31. PubMed ID: 19047656
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Oral bioavailability of dihydroartemisinin in Vietnamese volunteers and in patients with falciparum malaria.
    Binh TQ; Ilett KF; Batty KT; Davis TM; Hung NC; Powell SM; Thu LT; Thien HV; Phuöng HL; Phuong VD
    Br J Clin Pharmacol; 2001 Jun; 51(6):541-6. PubMed ID: 11422013
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy and effectiveness of dihydroartemisinin-piperaquine versus artesunate-mefloquine in falciparum malaria: an open-label randomised comparison.
    Smithuis F; Kyaw MK; Phe O; Aye KZ; Htet L; Barends M; Lindegardh N; Singtoroj T; Ashley E; Lwin S; Stepniewska K; White NJ
    Lancet; 2006 Jun; 367(9528):2075-85. PubMed ID: 16798391
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.